The Medicines and Healthcare products Regulatory Agency (MHRA) are reviewing their approach on how they engage and involve patients.
They are running a public consultation to better understand how to make sure that the patient voice is heard when safety issues, concerning medicines or medical devices, are identified and in the licensing of new medicines.
They would like to hear from:
- patient group representatives
- healthcare professionals